Generic Drug Companies Protected by Supreme Court Ruling

supreme court seal

According to last Thursday’s ruling from the U.S. Supreme Court, the makers of generic drugs cannot be sued for failing to sufficiently warn patients of their drugs’ dangerous side effects. Brand-name companies can still be held liable for patient injuries caused by insufficient warnings, but the same legal duty is not applicable to companies manufacturing [...]

Cancer-Drug Avastin on FDA Hot Seat

Breast Cancer Drug FDA Preview

Roche’s best-selling cancer drug, Avastin, is currently the subject of an unprecedented hearing set to take place this week. Federal regulators have scrutinized the once-promising drug after it proved to carry more risks than benefits in patients taking the medication as a treatment for breast cancer. In fact, the U.S. Food and Drug Administration granted [...]

Cholesterol Drugs in High Doses Increase Risk for Diabetes

Lipitor-Zocor-Cholesterol-Drugs/ RxRecall/The Maher Law Firm/ Frank Eidson

According to a study published in the Journal of the American Medical Association, Scottish researchers found that patients taking high doses of statins had an increased risk of developing diabetes and a lower risk of heart complication compared to those who take smaller amounts of the drugs. The study, which examined 5 major clinical trials [...]

FDA Advisors Reject Novartis Gout Drug


The FDA’s Arthritis Advisory Committee firmly voted against recommending the Novartis drug, Ilaris, as a treatment for gout. The 11 to 1 vote against backing the drug stemmed from safety concerns over the risk for patients to develop serious infections and other problems. While the panel noted that the data did demonstrate the drug is [...]

Recall of Risperdal and Risperidone Issued by J&J Company

Risperdal Lawyer

Following reports of a musty odor, Ortho-McNeil-Janssen Pharmaceuticals, a Johnson and Johnson company, issued a recall of its Risperdal and risperidone medications. The drugs, which are used to treat schizophrenia and other forms of psychosis, are the newest additions to the growing list of various products that have been recalled by J&J and its subsidiaries. [...]

Supreme Court Revives Baycol Class-Action Against Bayer


On Thursday, the Supreme Court unanimously agreed to revive a lawsuit against Bayer AG over its drug, Baycol. In 2001, the anti-cholesterol drug was withdrawn from the market following reports that it caused a severe and sometimes deadly muscle disorder. Kevin Smith and Shirley Sperlazza, two West Virginia residents, had originally filed a class-action lawsuit [...]

Diabetes Drug Liraglutide (Victoza) May Cause Thyroid Cancer

Victoza Lawyer

The U.S. Food and Drug Administration issued a warning to consumers this week regarding the potential risks associated with use of the diabetes drug, liraglutide (Victoza). Specifically, the agency warns that use of the drug may increase the risk for patients to develop thyroid cancer and pancreatitis. In addition to announcing the safety alert, the [...]

Use of Diabetes Drug Actos Linked to Increased Cancer Risk

actos | The Maher Law Firm

The Food and Drug Administration announced recently that prolonged use of Takeda Pharmaceutical’s diabetes drug, Actos (pioglitazone), may increase a patient’s risk for developing bladder cancer. The FDA also stated that product labeling would soon be updated to reflect the new information about the increased cancer risk. The warning was issued by the FDA following [...]

American Regent Issues Voluntary Recall of Hypertension Medication

American Regent

American Regent notified customers and distributors of its voluntary recall of a single lot of methyldopate HCL injection due to the presence of translucent particles of glass flakes. The glass flakes are said to range in size from less than 50 microns to 200 microns. This recall is the latest in a growing list of [...]

Long-Term Use of PLD Linked to Risk of Secondary Cancer

Pegylated Liposomal Doxorubicin, or PLD, is the common treatment for platinum-sensitive and platinum-resistant recurrent epithelial ovarian cancer. According to recent data presented at the 2011 Annual Meeting for the American Society of Clinical Oncology, long-term use of PLD may carry with it an increased risk of developing secondary cancer of the oral cavity. Dr. Timothy [...]